PURPOSE: To investigate the reliability and accuracy of two pseudo-continuous arterial spin labeling (pCASL) sequences, using two-dimensional (2D) gradient-echo echo planar imaging (EPI) and 3D gradient and spin echo (GRASE) as the readout, respectively. MATERIALS AND METHODS: Each sequence was performed twice 4 weeks apart on six normal control subjects, six elderly subjects with mild cognitive impairment (MCI), and one participant with Alzheimer's disease (AD). Eight of these subjects also underwent H2 (15) O positron emission tomography (PET) scans on the same day or proximal to their second MRI scan. The longitudinal repeatability of EPI and GRASE pCASL were evaluated with the intraclass correlation coefficient (ICC) and within-subject coefficient of variation (wsCV). RESULTS: The ICCs of global perfusion measurements were 0.697 and 0.413 for GRASE and EPI based pCASL respectively. GRASE pCASL also demonstrated a higher longitudinal repeatability for regional perfusion measurements across 24 regions-of-interests (ICC = 0.707; wsCV = 10.9%) compared with EPI pCASL (ICC = 0.362; wsCV = 15.3%). When compared with PET, EPI pCASL showed a higher degree of spatial correlation with PET than GRASE pCASL, although the difference was not statistically significant. CONCLUSION: The 3D GRASE pCASL offers better repeatability than 2D EPI pCASL, thereby may provide a reliable imaging marker for the evaluation of disease progression and treatment effects in MCI and early AD subjects.
PURPOSE: To investigate the reliability and accuracy of two pseudo-continuous arterial spin labeling (pCASL) sequences, using two-dimensional (2D) gradient-echo echo planar imaging (EPI) and 3D gradient and spin echo (GRASE) as the readout, respectively. MATERIALS AND METHODS: Each sequence was performed twice 4 weeks apart on six normal control subjects, six elderly subjects with mild cognitive impairment (MCI), and one participant with Alzheimer's disease (AD). Eight of these subjects also underwent H2 (15) O positron emission tomography (PET) scans on the same day or proximal to their second MRI scan. The longitudinal repeatability of EPI and GRASE pCASL were evaluated with the intraclass correlation coefficient (ICC) and within-subject coefficient of variation (wsCV). RESULTS: The ICCs of global perfusion measurements were 0.697 and 0.413 for GRASE and EPI based pCASL respectively. GRASE pCASL also demonstrated a higher longitudinal repeatability for regional perfusion measurements across 24 regions-of-interests (ICC = 0.707; wsCV = 10.9%) compared with EPI pCASL (ICC = 0.362; wsCV = 15.3%). When compared with PET, EPI pCASL showed a higher degree of spatial correlation with PET than GRASE pCASL, although the difference was not statistically significant. CONCLUSION: The 3D GRASE pCASL offers better repeatability than 2D EPI pCASL, thereby may provide a reliable imaging marker for the evaluation of disease progression and treatment effects in MCI and early AD subjects.
Authors: N Tzourio-Mazoyer; B Landeau; D Papathanassiou; F Crivello; O Etard; N Delcroix; B Mazoyer; M Joliot Journal: Neuroimage Date: 2002-01 Impact factor: 6.556
Authors: Jiongjiong Wang; Geoffrey K Aguirre; Daniel Y Kimberg; Anne C Roc; Lin Li; John A Detre Journal: Magn Reson Med Date: 2003-05 Impact factor: 4.668
Authors: Thomas F Floyd; Sarah J Ratcliffe; Jiongjiong Wang; Brooke Resch; John A Detre Journal: J Magn Reson Imaging Date: 2003-12 Impact factor: 4.813
Authors: María A Fernández-Seara; Ze Wang; Jiongjiong Wang; Heng-Yi Rao; Matthias Guenther; David A Feinberg; John A Detre Journal: Magn Reson Med Date: 2005-11 Impact factor: 4.668
Authors: Nathan A Johnson; Geon-Ho Jahng; Michael W Weiner; Bruce L Miller; Helena C Chui; William J Jagust; Maria L Gorno-Tempini; Norbert Schuff Journal: Radiology Date: 2005-03 Impact factor: 11.105
Authors: Sudipto Dolui; Marta Vidorreta; Ze Wang; Ilya M Nasrallah; Abass Alavi; David A Wolk; John A Detre Journal: Hum Brain Mapp Date: 2017-07-24 Impact factor: 5.038
Authors: Geoffrey Warnock; Pinar S Özbay; Felix P Kuhn; Daniel Nanz; Alfred Buck; Andreas Boss; Cristina Rossi Journal: J Cereb Blood Flow Metab Date: 2017-04-19 Impact factor: 6.200
Authors: Kirk I Erickson; George A Grove; Jeffrey M Burns; Charles H Hillman; Arthur F Kramer; Edward McAuley; Eric D Vidoni; James T Becker; Meryl A Butters; Katerina Gray; Haiqing Huang; John M Jakicic; M Ilyas Kamboh; Chaeryon Kang; William E Klunk; Phil Lee; Anna L Marsland; Joseph Mettenburg; Renee J Rogers; Chelsea M Stillman; Bradley P Sutton; Amanda Szabo-Reed; Timothy D Verstynen; Jennifer C Watt; Andrea M Weinstein; Mariegold E Wollam Journal: Contemp Clin Trials Date: 2019-08-26 Impact factor: 2.226
Authors: Manjunathan Nanjappa; Thomas Troalen; Josef Pfeuffer; Bénédicte Maréchal; Tom Hilbert; Tobias Kober; Fabien C Schneider; Pierre Croisille; Magalie Viallon Journal: MAGMA Date: 2020-10-13 Impact factor: 2.310
Authors: Lirong Yan; Collin Y Liu; Robert X Smith; Mayank Jog; Michael Langham; Kate Krasileva; Yufen Chen; John M Ringman; Danny J J Wang Journal: Neuroimage Date: 2015-09-10 Impact factor: 6.556